← Back to Clinical Trials
Recruiting NCT06324149

NCT06324149 Age-related Conditions in the Context of Multimorbidity and Frailty: Relative Weight of Frailty in Determining the Course and Outcomes of Different Chronic Diseases and Viceversa

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06324149
Status Recruiting
Phase
Sponsor IRCCS San Raffaele
Condition Frailty
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2024-03-07
Primary Completion 2026-02-28

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 100 Years
Study Type OBSERVATIONAL
All Conditions
Interventions
completion of scales and questionnaires; venous blood sampling; muscle ultrasound; cardiac ultrasound; electrocardiogram; bioelectrical impedance analysis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2024-03-07 with a primary completion date of 2026-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Observational study. Participants of the FRASNET study (9th March 2017, Protocol No. 24/INT/2017) who were evaluated in 2016 and 2017 will be contacted to be re-evaluated with multidimensional visits as part of the present study in order to assess trajectories and biomarkers of frailty and sarcopenia. Moreover, are going to evaluate with the same multidimensional visits patients with mild cognitive impairment and dementia followed up at the Neurologic Unit of the San Raffaele Hospital.

Eligibility Criteria

Inclusion Criteria: * Having participated in the FRASNET study or being a patient with mild cognitive impairment or dementia followed up at the Neurologic Unit of the San Raffaele Hospital * Ability to sign written informed consent * \> 18 years old Exclusion Criteria: * Life expectancy \< 6 months * Unwillingness to participate in the study * Unstable clinical disease(for ex. serious acute pathologies)

Contact & Investigator

Central Contact

Patrizia Rovere Querini, PhD, MD

✉ rovere.patrizia@hsr.it

📞 +390226433065

Frequently Asked Questions

Who can join the NCT06324149 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06324149 currently recruiting?

Yes, NCT06324149 is actively recruiting participants. Contact the research team at rovere.patrizia@hsr.it for enrollment information.

Where is the NCT06324149 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT06324149 clinical trial?

NCT06324149 is sponsored by IRCCS San Raffaele. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology